Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Diabetes rivalries get more complicated with new FDA warning on J&J's Invokana
Diabetes rivalries get more complicated with new FDA warning on J&J's Invokana
Diabetes rivalries get more complicated with new FDA warning on J&J's Invokana
Submitted by
admin
on September 14, 2015 - 11:01am
Source:
Fierce Pharma Marketing
News Tags:
diabetes
FDA
Invokana
JNJ
Jardiance
Boehringer Ingelheim
Eli Lilly
Headline:
Diabetes rivalries get more complicated with new FDA warning on J&J's Invokana
Do Not Allow Advertisers to Use My Personal information
